CD274 and nasopharyngeal carcinoma: Correspondingly, patients with high level of PD-L1 had a significantly reduced overall survival (Figure 5A), which was in consist with our previous study [16] and study conducted by Zhang et al [17] regarding primary NPC, indicating that PD-L1 might be a potential prognostic biomarker for both primary and recurrent NPC patients.